U0126
's information is
Birth and death years unknown
U0126 is a MEK1/2 inhibitor that is used to study MEK and related signaling pathways. This inhibitor is selective for both MEK1 and MEK2, two specific types of MEK (MAPK kinases) that are elements of the MAPK/ERK signaling pathway. This compound is usually studied in the context of cancer treatment, ischemia, and cellular oxidative stress. The compound is not approved by the FDA as a therapeutic a
* Calculated from Wikipedia data.
Accuracy is not guaranteed.
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C18H16N6S2 |
| Molar mass | 380.49 g·mol |
| 3D model (JSmol) | |
| |
| |
| (what is this?) (verify) | |
Look up "U0126" on WikipediaWikipedia Categories
Loading...